Efficiency of low dosage apatinib in post-first-line treatment of advanced lung adenocarcinoma

Chemotherapy is the standard treatment of in advanced lung adenocarcinoma patients without driver mutation. However, few drugs could be selected when diseases progressed after second-line treatment. As a small molecule inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2), apatinib wa...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Zeng, Da-Xiong, Wang, Chang-Guo, Lei, Wei, Huang, Jian-An, Jiang, Jun-Hong
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2017
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5630408/
https://ncbi.nlm.nih.gov/pubmed/29029508
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19908
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker